Oyama M - Search Results

1

[Continuous infusion therapy with low dose cytosine arabinoside and etoposide in acute myelogenous leukemia patients hardly tolerable for intensive combination chemotherapy].

Tsurumi H, Miura T, Yamada T, Sawada M, Nakamura N, Tomoda T, Takahashi T, Oyama M, Moriwaki H, Muto Y. Tsurumi H, et al. Among authors: oyama m. Rinsho Ketsueki. 1995 Jul;36(7):657-64. Rinsho Ketsueki. 1995. PMID: 7563593 Clinical Trial. Japanese.

2

Low-dose granulocyte colony-stimulating factor overcomes neutropenia in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness.

Hara T, Tsurumi H, Kasahara S, Kanemura N, Yoshikawa T, Goto N, Kojima Y, Yamada T, Sawada M, Takahashi T, Oyama M, Tomita E, Moriwaki H. Hara T, et al. Among authors: oyama m. Int J Hematol. 2005 Dec;82(5):430-6. doi: 10.1532/IJH97.05001. Int J Hematol. 2005. PMID: 16533747 Clinical Trial.

3

Therapeutic strategy of untreated de novo acute myeloid leukemia in the elderly: the efficacy of continuous drip infusion with low dose cytarabine and etoposide.

Tsurumi H, Kanemura N, Hara T, Kasahara S, Yamada T, Sawada M, Oyama M, Moriwaki H. Tsurumi H, et al. Among authors: oyama m. J Cancer Res Clin Oncol. 2007 Aug;133(8):547-53. doi: 10.1007/s00432-007-0203-3. Epub 2007 Apr 24. J Cancer Res Clin Oncol. 2007. PMID: 17453240 Clinical Trial.

4

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy.

Kanemura N, Tsurumi H, Kasahara S, Hara T, Yamada T, Sawada M, Goto N, Kitagawa J, Shimizu M, Oyama M, Moriwaki H. Kanemura N, et al. Among authors: oyama m. Hematol Oncol. 2008 Mar;26(1):33-8. doi: 10.1002/hon.834. Hematol Oncol. 2008. PMID: 17918772

5

[Acute megakaryoblastic leukemia with leukemia cutis, meningeal leukemia, and myelofibrosis].

Tsurumi H, Takahashi T, Koshino Y, Oyama M, Matsutomo K, Yasuda M, Moriwaki H, Muto Y. Tsurumi H, et al. Among authors: oyama m. Rinsho Ketsueki. 1991 Nov;32(11):1475-80. Rinsho Ketsueki. 1991. PMID: 1758056 Japanese.

6

[Cytarabine-induced pericarditis].

Yamada T, Tsurumi H, Hara T, Sawada M, Oyama M, Moriwaki H. Yamada T, et al. Among authors: oyama m. Rinsho Ketsueki. 1998 Nov;39(11):1115-20. Rinsho Ketsueki. 1998. PMID: 9866424 Japanese.

7

[Disappearance of residual disease confirmed by RT-PCR following induction chemotherapy in two hypoplastic leukemia patients with t(8;21)].

Sawada M, Tsurumi H, Yamada T, Hara T, Oyama M, Moriwaki H. Sawada M, et al. Among authors: oyama m. Rinsho Ketsueki. 1999 Apr;40(4):311-7. Rinsho Ketsueki. 1999. PMID: 10355140 Japanese.

8

[An elderly patient with myelodysplastic syndrome successfully treated with combination of granulocyte-colony stimulating factor and continuous-drip infusion of low-dose cytarabine and etoposide].

Yamada T, Tsurumi H, Hara T, Fukuno K, Goto H, Oyama M, Moriwaki H. Yamada T, et al. Among authors: oyama m. Rinsho Ketsueki. 2000 Mar;41(3):218-21. Rinsho Ketsueki. 2000. PMID: 10774251 Japanese.

9

[Complete remission of plasmablastic IgD lambda multiple myeloma induced by continuous infusion of low-dose cytarabine and etoposide].

Fukuno K, Tsurumi H, Yamada T, Oyama M, Moriwaki H. Fukuno K, et al. Among authors: oyama m. Rinsho Ketsueki. 2000 Jun;41(6):513-8. Rinsho Ketsueki. 2000. PMID: 10921352 Japanese.

10

A variant form of acute promyelocytic leukemia with marked myelofibrosis.

Fukuno K, Tsurumi H, Yoshikawa T, Yamada T, Oyama M, Moriwaki H. Fukuno K, et al. Among authors: oyama m. Int J Hematol. 2001 Oct;74(3):322-6. doi: 10.1007/BF02982068. Int J Hematol. 2001. PMID: 11721970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

747 results

Search Page

Filters